Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 121,042 | 102,712 | 9,079 | 22,454 |
| Receivables | 3,458 | 1,706 | 2,452 | 185 |
| TOTAL | $126,597 | $105,420 | $12,381 | $23,374 |
| Non-Current Assets | ||||
| PPE Net | 300 | 235 | 235 | 534 |
| Other Non-Current Assets | 307 | 231 | 1,456 | 161 |
| TOTAL | $607 | $466 | $1,691 | $695 |
| Total Assets | $127,204 | $105,886 | $14,072 | $24,069 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 3,436 | 5,928 | 3,641 | 2,197 |
| Accounts payable and accrued liabilities | 4,105 | 1,881 | 2,018 | 800 |
| Accrued Expenses | 9,477 | 5,290 | 2,303 | 3,977 |
| TOTAL | $17,276 | $13,191 | $8,661 | $6,974 |
| Non-Current Liabilities | ||||
| Long Term Debt | 1,124 | 4,560 | 7,881 | 5,551 |
| Deferred Revenues | 258 | 92 | 699 | N/A |
| Other Non-Current Liabilities | 238 | 327 | 738 | 306 |
| TOTAL | $1,362 | $4,887 | $8,619 | $5,857 |
| Total Liabilities | $18,638 | $18,078 | $17,280 | $12,831 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 1,549 | 1,290 | N/A | N/A |
| Common Shares | 31 | 26 | N/A | N/A |
| Retained earnings | -186,463 | -119,721 | -90,085 | -74,998 |
| Other shareholders' equity | 0 | 0 | 79,841 | 79,841 |
| TOTAL | $108,566 | $87,808 | $-3,208 | $11,238 |
| Total Liabilities And Equity | $127,204 | $105,886 | $14,072 | $24,069 |